BGMD Share Price

Open 0.05 Change Price %
High 0.05 1 Day 0.00 0.00
Low 0.05 1 Week 0.00 0.00
Close 0.05 1 Month 0.00 0.00
Volume 22800 1 Year -0.14 -73.68
52 Week High 0.20
52 Week Low 0.00
BGMD Important Levels
Resistance 2 0.05
Resistance 1 0.05
Pivot 0.05
Support 1 0.05
Support 2 0.05
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DCTH 0.13 -13.33%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
More..
NASDAQ USA Top Gainers Stocks
ARCI 1.45 137.70%
FALC 0.40 60.00%
AMCF 0.03 50.00%
LOCM 0.09 50.00%
OPXAW 0.10 42.86%
VRTA 4.50 38.46%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
ATRM 1.70 21.43%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
PTSX 0.05 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

BG Medicine, Inc. (NASDAQ: BGMD)

BGMD Technical Analysis 5
As on 21st Aug 2017 BGMD Share Price closed @ 0.05 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.09 & Strong Sell for SHORT-TERM with Stoploss of 0.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
BGMD Target for August
1st Target up-side 0.08
2nd Target up-side 0.11
3rd Target up-side 0.13
1st Target down-side 0.02
2nd Target down-side -0.01
3rd Target down-side -0.03
BGMD Other Details
Segment EQ
Market Capital 35047004.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.bg-medicine.com
BGMD Address
BGMD
880 Winter Street
Suite 210
Waltham, MA 02451
United States
Phone: 781-890-1199
Fax: 781-895-1119
BGMD Latest News
Interactive Technical Analysis Chart BG Medicine, Inc. ( BGMD NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on BG Medicine, Inc.
BGMD Business Profile
BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque. In March 2011, the Company entered into a supply agreement with Health Diagnostic Laboratory, Inc. (HDL), pursuant to which HDL agreed to purchase manual galectin-3 test kits from the Company and to offer galectin-3 testing services to physicians in the United States. This manual version of Its Galectin-3 test is being marketed in the United States through a number of regional and national laboratory testing facilities. In addition, it has partnered with four diagnostic instrument manufacturers, which are developing automated instrument versions of its galectin-3 test.